Word on the street is that marijuana in the US might soon be classified as not as threatening as LSD and heroin, thus allowing cannabis companies like Australia-based Little Green Pharma (ASX: LGP) to chart their entry. Sources in the US Drug Enforcement Administration have confirmed the regulator will recommend reclassifying cannabis from Schedule I
Read More
A healthcare policy change passed in France is likely to see the country quickly targeted by medicinal cannabis companies with Little Green Pharma (ASX: LGP) quick to confirm their plans to increase product distribution to the country thanks to newly favourable healthcare legislation. The recent amendment to the Projet de loi de financement de la
Read More
Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1 billion by 2028. Both Aussies and Europeans are big consumers of cannabis, making them attractive markets for medical cannabis companies like Little Green Pharma (ASX: LGP). Little Green Pharma posted a 37% revenue spike to
Read More
The company at the forefront of the cannabis sector has also ventured into the psychedelic therapy treatment industry, demonstrating a commitment to offer alternative treatments to Little Green Pharma (ASX: LGP) and its subsidiary Reset Mind Sciences, who announced a fresh alliance with Health Insurance Fund Australia (HIF). Joining forces to tackle mental health, the
Read More
Although it doesn’t apply to me, many of you may remember the early mornings during adolescence when you were throwing yourself around in a club, parading a locked-jaw, and beaming pupils so wide it would be hard to deny that you weren’t on something. Well, chances are, you had consumed MDMA, or if you were
Read More
Little Green Pharma (ASX: LGP) has been on a roll this quarter. Increasing cash receipts by 35% from $4.4 million to $6 million, the Company has made strides in its cannabis operations. The influx of revenue was thanks to the first shipment of new strains from Denmark, which earned more than $0.5 million over five
Read More